| Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
|---|---|---|---|---|---|
| 6530 Q-TOF/C18 NEGATIVE ION MODE | N-ACETYL-ASPARTIC ACID (M-H)- | 4857 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | N-ACETYL-ASPARTIC ACID (M-H)- | 7039 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | N-ACETYL-ASPARTIC ACID (M-H)- | 11100 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | N-ACETYL-ASPARTIC ACID (M-H)- | Peak area | IPMN | LGD | |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | N-ACETYL-ASPARTIC ACID (M-H)- | Peak area | MCN | LGD | |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | N-ACETYL-ASPARTIC ACID (M-H)- | Peak area | SCA | N/A | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | N-ACETYL-ASPARTIC ACID (M+Na)+ | 1621 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | N-ACETYL-ASPARTIC ACID (M+Na)+ | 3181 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | N-ACETYL-ASPARTIC ACID (M+Na)+ | 6292 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | N-ACETYL-ASPARTIC ACID (M+Na)+ | 7309 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | N-ACETYL-ASPARTIC ACID (M+Na)+ | Peak area | IPMN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | N-ACETYL-ASPARTIC ACID (M+Na)+ | Peak area | MCN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | N-ACETYL-ASPARTIC ACID (M+Na)+ | Peak area | SCA | N/A |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|